A coalition of leading plaintiffs' law firms, including Williams Hart & Boundas LLP, has secured a $7.25 billion settlement class action against Monsanto to resolve thousands of existing and future claims linking Roundup exposure to non-Hodgkin lymphoma (NHL). The settlement, filed on February 17, 2026, in the City of St. Louis Circuit Court, will establish a structured compensation framework for individuals diagnosed with NHL after exposure to Monsanto's glyphosate-based herbicide.
The settlement involves a team of firms: Williams Hart & Boundas, Waters Kraus Paul & Siegel, Motley Rice, Seeger Weiss, and the Holland Law Firm. Over recent years, juries nationwide have returned significant verdicts linking Roundup to NHL, while tens of thousands of claims remain pending in state and federal courts. The U.S. Supreme Court has accepted an appeal to review the validity of these claims, adding urgency to the resolution.
"After years of pressing cases against Monsanto and in light of the fact that the U.S. Supreme Court has accepted an appeal to review the validity of these Roundup claims, we are pleased to achieve a resolution that we believe is acceptable based on the current circumstances," said John Eddie Williams, Jr., Founding and Managing Partner of Williams Hart & Boundas LLP.
Under the proposed settlement, Monsanto will fund up to $7.25 billion to compensate a class that includes virtually all existing and certain future Roundup cancer claims. The agreement provides a structured and comprehensive resolution framework for individuals diagnosed with NHL following exposure to the herbicide. Eligible class members have the right to opt out and pursue individual claims if they choose.
Williams Hart & Boundas LLP, founded over 40 years ago, is a nationally recognized Houston-based plaintiffs' law firm dedicated to representing injured individuals and their families. The firm has extensive experience in products liability and mass torts, focusing on pesticides, pharmaceuticals, and medical devices, as well as catastrophic injury cases and complex commercial litigation.
